Biopreservation Market Analysis And Forecast To 2032: By Product (Equipment, Media, LIMS), By Application (Regenerative Medicine, Bio-banking, Drug Discovery), By Cell Providers Volume (CD34+, CD19+, MSC, iPSC, hESC, Tumor Cells, Others), And Region

The global Biopreservation Market was valued at USD 2.2 Billion in 2022 and it is anticipated to grow up to USD 26.7 Billion by 2032, at a CAGR of 28.5% during the forecast period.

Bio-preservative is a technique for preserving cells, organs, and tissues outside the natural environment to extend shelf life and to ensure the stability and purity of cells, organ, and tissues. Bio-preservation plays a key role in the numerous clinical application which consists of cell-based technology. The equipment of Biopreservation comprises of the freezers, refrigerators, liquid nitrogen tanks etc. Biobanking is a kind of biopreservation which is commonly used in in medical research like genomics research and for personalized medicine.

Market Trends and Drivers

In recent years, there has been an upsurge in demand for the use of biopreservation to develop biological products in R&D of various sectors such as immunotherapies, vaccine production, antibody production, enzyme technology, and biologically produced chemicals. This impact is due to the rising number of chronic disease incidences globally. According to the Centers for Disease Control and Prevention (CDC), the leading cause of disease-related mortality in adults is the rising prevalence of cardiovascular disorders and cancer in the U.S. Furthermore, the government and private sectors have shown interest and supported funding activities in research and development, which has led to immense market developments. In past years, the growing demand for preserving stem cells and developing biological medicines and products has gained investors’ focus on the field. This considerable healthcare spending is expected to grow in the market in the forecast period. However, the growing market for biopreservation is associated with the unavailability of skilled professionals and lacking stringent cyber securities. This is due to the high cost associated with training of labor and standardization of software. This can have an impact on overall market growth.

Market Restraints and Challenges

R&D in media solutions, which allow room temperature storage of biospecimens is expected to hinder growth of the global biopreservation market. For instance, Biomatrica, Inc. offers room temperature sample stabilization media solutions such as DNA stable and RNA stable. Such solutions pose a threat to demand for freezers and refrigerators, thereby restricting the market growth. Moreover, high cost recovery model of biobanking is also expected to limit adoption of biopreservation..

The report analyses the global Biopreservation Market based on product, application, cell provider volume, and region.
Global Biopreservation Market by Product
By product, the market is segmented into Equipment, Media, and Laboratory Information Management System (LIMS). The equipment segment held the largest revenue share of over xx% in 2022 due to the rising demand for bio-banking to preserve stem cells, DNA, plasma, and tissue culture. The widespread acceptance and utilization of preservation have led to adequate storage capacity and low maintenance, which is expected to boost market growth. The media segment is expected to expand at a lucrative CAGR of xx% from 2022 to 2032. The segment has the potential to grow as it is a crucial part of the biopreservation process. Media applications offer more features and details, which allow researchers to access and share research data and analyses, thereby improving their ability to research, diagnose, monitor, and treat health disorders, which are anticipated to drive the market in the forecast period.
Global Biopreservation Market by Application
By application, the Biopreservation Market is classified into Regenerative Medicine, Bio-banking, and Drug Discovery. The biobanking segment dominated the global market with a revenue share of over 70.0% in 2021. Rising awareness regarding stem cell preservation, increasing acceptance of sperm and egg banking, and utilization of assistant reproductive technology in animals are fueling the segment growth. Pharmaceutical companies have collaborations with reserve bio-banks and hospitals for tissue preservation. The regenerative medicine segment is expected to expand at the highest CAGR of 30.3% in the forecast period owing to increasing demand for technologically advanced bio-storage techniques. In addition, the launch of specific preservation techniques is expected to propel the segment growth in the coming years.
Global Biopreservation Market by Cell Provider Volume
Based on cell provider volume. It is segmented into CD34+, CD19+, MSC, iPSC, hESC, Tumor Cells, and Others. Tumor cells held the largest revenue share of over 15.0% in 2021. This can be attributed to increasing diagnosis, research, and treatment activities that involve the development of cancer therapies. Tumor cells are utilized for biomarkers in various cancer studies such as prostate, colon, and breast carcinomas. The clinical utility of tumor cells has further supported the segment growth. The iPSC segment is projected to grow rapidly in the forecast period owing to increasing use in restorative therapy because of its ability to propagate without any limit. It involves a wide range of biomedical research concentrated on cells, associated with disease modeling, drug discovery, organ synthesis, RBCs, and tissue repairs. Rising funding assistance further offers a lucrative opportunity for market growth.

Geographical Analysis of Global Biopreservation Market

Region-wise, it is studied across North America, Europe, Asia Pacific, and the Rest of the World. The North American market is primarily driven by the rise in demand for the preservation of blood, solid tissue specimens, including paraffin-embedded or frozen bio-specimen of tumors, and other tissues (like peripheral blood cells, bone marrow, and stem cells-derived cord blood and its derivatives), across multiple research institutes, pathological centers, and hospitals. The surge in the government's investment in drug discovery is projected to boost the biopreservation utility for the preservation of cells, tissues, and organs ex-vivo for the purpose of storage, shipment, and transportation. For instance, the Canadian government invested USD 45 million in the current year over the next three years to the Stem Cell Network to encourage stem cell and regenerative medicine research. Such investments are anticipated to boost the utility and demand of biopreservation in the region, thereby boosting market growth during the forecast period.

Additionally, advancements in technology, increasing product approvals, partnerships, and acquisitions by key players are helping in the market growth. For instance, in February 2022, OriGen Biomedical Inc., a global medical device manufacturer of cryopreservation, cell culture, and respiratory products, launched CryoStore FLEX Freezing Bag in the United States and Europe. The CryoStore FLEX Bag is designed for the cryopreservation of blood components and offers the multi-chamber flexibility of small-volume dose solutions.

Major Players in the Global Biopreservation Market

The key players in the Biopreservation Market  are Azenta US, Inc.; Biomatrica, Inc.; BioLife Solutions; MVE Biological Solutions; LabVantage Solutions, Inc.; Taylor-Wharton; Thermo Fisher Scientific, Inc.; Panasonic Corporation; X-Therma Inc.; PrincetonCryo.; Stirling Ultracold among others.

COVID-19 Impact:

The impact of COVID-19 was significant owing to the increased research and development activities of pharmaceutical and biotech companies to prepare and manufacture a vaccine, which required biopreservation. For instance, an article published in Stem Cells Translational Medicine Journal stated that the pandemic resulted in the USFDA approving EUA for three mRNA vaccines that Pfizer-BioNTech manufactured in December 2020, Moderna in December 2020, and Janssen in February 2021. The shipping and storage requirements for these vaccines (ultra-cold vs. refrigerated) necessitated bioprocessing methods. Thus, the COVID-19 pandemic is expected to impact the market significantly.

Recent Developments:

• In October 2022, Azenta, Inc. acquired B Medical Systems S.á r.l and its subsidiaries, a provider of temperature-controlled storage and transportation solutions that enables the delivery of life-saving treatments across the globe.
• In July 2022, Cellutions BioStorage, a research-to-launch Cryopreservation Bank, was inaugurated in Chennai, India. Cellutions BioStorage is a full-service biomaterial storage and logistics provider that works with biopharmaceutical firms looking to outsource all aspects of supply chain management throughout the course of a product's life cycle. The recently-launched facility is spread over 25,000 square feet and has top-notch infrastructure
• In March 2022, Biolife Solutions announced its expansion plan in the USD 400 million bio storage service market.
• In January 2022, Biolife Solutions collaborated with Seattle Children’s to improve viral vector and cell and gene therapy manufacturing.

Frequently Asked Questions

Q1. How big is the Biopreservation Market?Ans. The global Biopreservation Market was valued at USD 2.2 Billion in 2022 and it is anticipated to grow up to USD 26.7 Billion by 2032, at a CAGR of 28.5% during the forecast period.Q2. What is the Biopreservation Market growth rate?Ans. The growth rate of the Biopreservation market is 28.5%Q3. Which region holds a major market share for the market?Ans. North America holds a major market share of the Biopreservation Market in 2022.Q4. Which segment accounted for the largest Biopreservation Market share?Ans. By application, the Regenerative Medicine segment accounted for the largest Biopreservation Market share.Q5. Who are the key players in the kidney stones management market?Ans. The global Biopreservation Market report includes players such  Azenta US, Inc.; Biomatrica, Inc.; BioLife Solutions; MVE Biological Solutions; LabVantage Solutions, Inc.; Taylor-Wharton; Thermo Fisher Scientific, Inc.; Panasonic Corporation; X-Therma Inc.; PrincetonCryo.; Stirling Ultracold. among others.Q6. What are the factors driving the Biopreservation Market growth?Ans. The major factors driving the growth of the market are increasing investment in research and development activities.Q7. What are the key growth strategies of Biopreservation Market players?Ans. The key growth strategies of Biopreservation Market players are product launch and product approval.Q8. Which region will provide more business opportunities for the Biopreservation Market during the forecast period?Ans. The Asia-Pacific region will provide more business opportunities for the Biopreservation Market during the forecast period.

Please Note: This report will be delivered by publisher within 3-4 business days of order confirmation.